{"id":"NCT00249249","sponsor":"Kowa Research Europe","briefTitle":"Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels","officialTitle":"Study of Pitavastatin 2 mg vs. Atorvastatin 10 mg and Pitavastatin 4 mg vs. Atorvastatin 20 mg (Following Up Titration) in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-10","primaryCompletion":null,"completion":"2006-11","firstPosted":"2005-11-07","resultsPosted":"2009-12-16","lastUpdate":"2010-01-12"},"enrollment":830,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Primary Hypercholesterolemia","Dyslipidemia"],"interventions":[{"type":"DRUG","name":"Pitavastatin","otherNames":[]},{"type":"DRUG","name":"Atorvastatin","otherNames":[]}],"arms":[],"summary":"The purpose of this study is to compare the efficacy of pitavastatin with that of atorvastatin.","primaryOutcome":{"measure":"Percent Change From Baseline Low Density Lipoprotein-cholesterol (LDL-C) at Week 12","timeFrame":"Baseline to 12 weeks","effectByArm":[{"arm":"Pitavastatin 2 mg QD","deltaMin":-37.89,"sd":13.841},{"arm":"Atorvastatin 10 mg QD","deltaMin":-38.76,"sd":14.582},{"arm":"Pitavastatin 4 mg QD","deltaMin":-45.5,"sd":14.005},{"arm":"Atorvastatin 20 mg QD","deltaMin":-43.9,"sd":15.853}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":29},"locations":{"siteCount":192,"countries":["Denmark","Finland","Germany","India","Israel","Italy","Netherlands","Norway","Poland","Russia","Spain","Sweden","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":316},"commonTop":["nasopharyngitis","myalgia","constipation"]}}